337
Participants
Start Date
January 31, 2006
Primary Completion Date
May 31, 2007
Study Completion Date
December 31, 2008
pegylated filgrastim and filgrastim
patients were administered pegylated filgrastim 100 ug/kg in cycle 1 and filgrastim 5 ug/kg/d in cycle 2
filgrastim and pegylated filgrastim
patients received filgrastim 5 ug/kg/d in cycle 1 and pegylated filgrastim 100 ug/kg in cycle 2
Fujian Cancer Hospital
OTHER_GOV
Beijing Chest Hospital
OTHER
Hospital affiliated to Academy of Military Medical Sciences
UNKNOWN
Tianjin Medical University Cancer
UNKNOWN
Fudan University
OTHER
First Hospital of China Medical University
OTHER
Hunan Cancer Hospital
OTHER
West China Hospital
OTHER
The Second Affiliated Hospital of Dalian Medical University
OTHER
Peking University Third Hospital
OTHER
Tianjin People's Hospital
OTHER
Qilu Hospital of Shandong University
OTHER
Zhejiang Cancer Hospital
OTHER
Changhai Hospital
OTHER
Chinese Academy of Medical Sciences
OTHER